Hsp90-targeted sn-38 conjugate pen-866 Uses, Dosage, Side Effects and more
Hsp90-targeted sn-38 conjugate pen-866 is under investigation in clinical trial NCT03221400 (Hsp90-targeted sn-38 conjugate pen-866 in Patients With Advanced Solid Malignancies).
| Trade Name | Hsp90-targeted sn-38 conjugate pen-866 |
| Generic | PEN-866 |
| PEN-866 Other Names | Hsp90-targeted sn-38 conjugate pen-866 |
| Type | |
| Formula | C49H49N7O9 |
| Weight | Average: 879.971 Monoisotopic: 879.359176186 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
